Skip to main content

Advertisement

Fig. 2 | Cancer Communications

Fig. 2

From: Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification

Fig. 2

The prognostic significance of MYCN amplification and 11q23 deletion in patients with bone marrow metastatic neuroblastoma. a, b Event-free survival (EFS) and overall survival (OS) of the 101 patients stratified by MYCN gene. c, d EFS and OS of the 101 patients stratified by 11q23 status. e, f EFS and OS of the 89 patients without MYCN amplification stratified by 11q23 status. g, h EFS and OS of the 101 patients stratified by combined assessment of MYCN and 11q23 statuses

Back to article page